Kin Meds Review

Kin Meds: a one-account GLP-1 and longevity store, with a few transparency caveats

Kin Meds is a broad direct-to-consumer wellness platform that happens to do weight loss well. It is not a dedicated GLP-1 specialist. It carries LegitScript certification, sells both compounded and brand-name medications, and goes further than most peers by bundling a full longevity menu onto a single login — Sermorelin, NAD+, glutathione, TRT, plus hair, skin and sexual-health protocols. If you want to run more than one program at once without juggling logins and clinicians, that breadth is the real draw. If you only want the cleanest, most accountable path to a GLP-1, the spread is a reason to look closely.

How the pricing actually works

Every price Kin Meds publishes is a 'starting at' figure tied to a plan, not a flat per-dose rate. Treat the headline numbers as entry points that climb as your dose does. Compounded semaglutide starts a hair under two hundred dollars a month. Compounded tirzepatide starts around two hundred fifty. The brand-name tier — Wegovy injection and pill, Zepbound, and Foundayo — advertises an entry price of $199 a month.

There is one genuine catch buried in that brand number. For Wegovy and Zepbound, $199 a month is the insured or savings-card entry tier. Cash-pay patients without coverage should expect to pay materially more, since the standard cash pen runs into the high hundreds a month elsewhere. Foundayo is the exception — its $199 starter matches what the manufacturer's own direct cash channel charges. The compounded side is plain cash pricing. A first-order promo knocks a low-two-figure amount off your first month, bringing compounded semaglutide down to about $146. For context, the category median sits near $170 a month, so Kin Meds' compounded rates land in the normal middle of the market rather than at the bargain end.

The medication menu is unusually wide

Few telehealth providers offer this many ways to take a GLP-1. Kin Meds carries the standard compounded semaglutide and tirzepatide injections and the brand-name FDA-approved drugs, including the newer oral Wegovy pill and Foundayo. More unusually, it also sells sublingual GLP-1 drops and a GLP-1/GIP B12 drop. That last format is a real differentiator if needles are a dealbreaker for you. It is also less studied than the injectable versions, so go in clear-eyed about that trade-off.

• Compounded semaglutide and tirzepatide injections
• Brand-name Wegovy (injection and pill), Zepbound, and Foundayo
• Sublingual 'Personalized GLP-1' drops and a GLP-1/GIP B12 drop — an uncommon no-needle option
• A separate longevity stack: Sermorelin, NAD+, glutathione, TRT, hair, skin and sexual health

On the compounded medications, Kin Meds shows the required FDA disclaimer in plain sight: compounded drugs have not been evaluated or approved by the FDA for safety, efficacy, or quality. That is the honest, expected disclosure for this product class. It applies to every compounding-based provider, not just Kin Meds.

Who dispenses your medication — and who's behind the brand

Kin Meds is clear that it is a patient-management and intake platform, not a pharmacy. It partners with independent licensed physician networks for the clinical review, and a third-party pharmacy fills the prescription. The wrinkle: that pharmacy partner is not named anywhere public. Its terms also note that you may route your prescription to a pharmacy of your choice. So you are trusting the platform and its physician network more than any specific, identifiable dispensary.

Corporate transparency is the weakest part of the picture, and it's worth being upfront about. The legal entity name and state of incorporation are not disclosed. The site shows two different addresses — one in Manhattan Beach, California and one in Columbia, Maryland — with no entity tying them together. The terms set Georgia as the governing law with binding arbitration in San Diego. The privacy-policy contact email belongs to the site's marketing agency rather than a Kin Meds inbox. None of that is evidence of wrongdoing, and the LegitScript seal is a meaningful positive signal. But it does mean you can't easily work out who you're contracting with.

Who should choose Kin Meds — and who should skip it

Choose it if you value one-stop breadth. A member who wants a GLP-1 plus, say, NAD+ or TRT managed on the same account will find that convenience hard to match elsewhere. The needle-averse should also look here for the sublingual drops. The published compounded pricing is fair, the brand-name catalog is current, and the telehealth flow — questionnaire, provider review, tailored plan, ongoing support — is clearly laid out.

Skip it, or at least slow down, if you're a cash-pay patient drawn in by the $199 brand price. Confirm your real out-of-pocket cost before committing, because that figure assumes coverage. Think twice if you want a named pharmacy, documented lab work, and a clearly described dose-titration plan; those details aren't spelled out. And if you simply want a focused GLP-1 specialist, remember that Kin Meds spreads across eight-plus health categories. Weight loss is one line on a long menu, not the whole business.

Trust and safety: solid seal, thin paperwork

Kin Meds has an FDA warning letter on file, covered in the regulatory notice below. LegitScript certification plus disclosed physician-network oversight are real points in its favor. The pricing on the site is clear and current. What holds it back is the missing entity name, the unnamed pharmacy, the mismatched addresses, and the undisclosed per-state availability. You can read how we weigh these factors in our scoring methodology.

Bottom line

Kin Meds is a legitimate, LegitScript-certified way to get a GLP-1 — compounded or brand, injectable or sublingual — with the rare bonus of a full longevity and wellness stack on the same account. The compounded prices are reasonable and the brand catalog is up to date. Just price your real cost carefully, since the $199 brand tier assumes insurance. And accept that you're trading some corporate and pharmacy transparency for that one-account convenience. For multi-protocol members it's a strong, practical pick. For someone who wants a single, fully accountable GLP-1 specialist, there are tighter options.

If you're weighing alternatives, Eden ($198/month) and Breeze Meds ($199/month) are among the closest options we track to Kin Meds.